Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.

Elkhaled A, Jalbert LE, Phillips JJ, Yoshihara HA, Parvataneni R, Srinivasan R, Bourne G, Berger MS, Chang SM, Cha S, Nelson SJ.

Sci Transl Med. 2012 Jan 11;4(116):116ra5. doi: 10.1126/scitranslmed.3002796.

PMID:
22238333
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Miniature magnetic resonance system for point-of-care diagnostics.

Issadore D, Min C, Liong M, Chung J, Weissleder R, Lee H.

Lab Chip. 2011 Jul 7;11(13):2282-7. doi: 10.1039/c1lc20177h. Epub 2011 May 5.

PMID:
21547317
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.

Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Galbán S, Sebolt-Leopold JS, Rehemtulla A, Ross BD.

Clin Cancer Res. 2011 Jul 15;17(14):4751-60. doi: 10.1158/1078-0432.CCR-10-2098. Epub 2011 Apr 28.

PMID:
21527563
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Highly magnetic core-shell nanoparticles with a unique magnetization mechanism.

Yoon TJ, Lee H, Shao H, Weissleder R.

Angew Chem Int Ed Engl. 2011 May 9;50(20):4663-6. doi: 10.1002/anie.201100101. Epub 2011 Apr 14. No abstract available.

PMID:
21495138
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Micro-NMR for rapid molecular analysis of human tumor samples.

Haun JB, Castro CM, Wang R, Peterson VM, Marinelli BS, Lee H, Weissleder R.

Sci Transl Med. 2011 Feb 23;3(71):71ra16. doi: 10.1126/scitranslmed.3002048.

PMID:
21346169
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'.

Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J.

Semin Immunopathol. 2011 Sep;33(5):455-67. doi: 10.1007/s00281-011-0250-3. Epub 2011 Feb 12. Review.

PMID:
21318413
[PubMed - indexed for MEDLINE]
7.

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J.

Nat Commun. 2011 Feb 1;2:180. doi: 10.1038/ncomms1180.

PMID:
21285958
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical relevance of microparticles from platelets and megakaryocytes.

Italiano JE Jr, Mairuhu AT, Flaumenhaft R.

Curr Opin Hematol. 2010 Nov;17(6):578-84. doi: 10.1097/MOH.0b013e32833e77ee. Review.

PMID:
20739880
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection.

Haun JB, Devaraj NK, Hilderbrand SA, Lee H, Weissleder R.

Nat Nanotechnol. 2010 Sep;5(9):660-5. doi: 10.1038/nnano.2010.148. Epub 2010 Aug 1.

PMID:
20676091
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Targeting the dynamic HSP90 complex in cancer.

Trepel J, Mollapour M, Giaccone G, Neckers L.

Nat Rev Cancer. 2010 Aug;10(8):537-49. doi: 10.1038/nrc2887. Review.

PMID:
20651736
[PubMed - indexed for MEDLINE]
11.

The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.

Zhu H, Woolfenden S, Bronson RT, Jaffer ZM, Barluenga S, Winssinger N, Rubenstein AE, Chen R, Charest A.

Mol Cancer Ther. 2010 Sep;9(9):2618-26. doi: 10.1158/1535-7163.MCT-10-0248. Epub 2010 Jul 19.

PMID:
20643786
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Kulasingam V, Pavlou MP, Diamandis EP.

Nat Rev Cancer. 2010 May;10(5):371-8. doi: 10.1038/nrc2831. Epub 2010 Apr 12. Review.

PMID:
20383179
[PubMed - indexed for MEDLINE]
13.

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

Tsien C, Galbán CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence T, Ross BD.

J Clin Oncol. 2010 May 1;28(13):2293-9. doi: 10.1200/JCO.2009.25.3971. Epub 2010 Apr 5.

PMID:
20368564
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.

PMID:
20129251
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM.

Nature. 2009 Dec 10;462(7274):739-44. doi: 10.1038/nature08617. Epub .

PMID:
19935646
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Membrane vesicles as conveyors of immune responses.

Théry C, Ostrowski M, Segura E.

Nat Rev Immunol. 2009 Aug;9(8):581-93. doi: 10.1038/nri2567. Epub 2009 Jun 5. Review.

PMID:
19498381
[PubMed - indexed for MEDLINE]
17.

Exosomes: proteomic insights and diagnostic potential.

Simpson RJ, Lim JW, Moritz RL, Mathivanan S.

Expert Rev Proteomics. 2009 Jun;6(3):267-83. doi: 10.1586/epr.09.17. Review.

PMID:
19489699
[PubMed - indexed for MEDLINE]
18.

Exosomes--vesicular carriers for intercellular communication.

Simons M, Raposo G.

Curr Opin Cell Biol. 2009 Aug;21(4):575-81. doi: 10.1016/j.ceb.2009.03.007. Epub 2009 May 11. Review.

PMID:
19442504
[PubMed - indexed for MEDLINE]
19.

The parametric response map is an imaging biomarker for early cancer treatment outcome.

Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Ross DJ, Rehemtulla A, Ross BD.

Nat Med. 2009 May;15(5):572-6. doi: 10.1038/nm.1919. Epub 2009 Apr 19.

PMID:
19377487
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.

Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.

Mol Cancer Res. 2009 Feb;7(2):275-84. doi: 10.1158/1541-7786.MCR-07-2183. Epub 2009 Feb 10.

PMID:
19208749
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk